Early-Life and Reproductive Factors Shape the Risk of Aggressive Breast Cancer Subtypes Among Ethiopian Women: A Multicenter Analysis
This multicenter study of Ethiopian women reveals that early-life and reproductive factors, specifically early menarche, short breastfeeding duration, and low parity, are significantly associated with an increased risk of aggressive breast cancer subtypes such as triple-negative and HER2-enriched disease.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Breast cancer is not a single disease but a collection of different conditions that happen to start in the same place. While they all begin as tumors in breast tissue, they behave very differently once they form. Some grow slowly and respond well to hormone treatments, while others are aggressive, spreading quickly and resisting standard therapies. Scientists have learned to sort these tumors into specific groups by looking at the proteins on their surface, much like checking a key to see which lock it fits. Two of the most difficult groups to treat are those that lack the usual hormone receptors and those that overproduce a specific growth protein; these are the types that often lead to the worst outcomes. Understanding why some women develop these aggressive forms while others do not is a major goal for researchers, especially in regions where these dangerous types appear more frequently than in the rest of the world.
In Ethiopia, breast cancer is the most common cancer affecting women, and a significant portion of these cases turn out to be the aggressive varieties that are hardest to manage. For a long time, doctors and scientists in the region did not have clear data on how a woman's life history—specifically her reproductive choices and experiences—might influence which type of cancer she develops. A new study conducted across two major hospitals in Addis Ababa set out to fill this gap. Researchers gathered information from 400 women who had been diagnosed with breast cancer, carefully examining their medical records and asking detailed questions about their lives. They wanted to see if factors like the age a woman started menstruating, how many children she had, and how long she breastfed her children were linked to the specific molecular type of cancer she had.
The team focused on comparing the women who had the aggressive forms of the disease against those with the more common, less aggressive types. They looked at the entire history of the women, from when they first started their periods to their current age, and cross-referenced this with the biological makeup of their tumors. The study revealed a clear pattern in the lives of the women who developed the most dangerous forms of the cancer. Women who began menstruating before the age of twelve were significantly more likely to have the aggressive types of tumors. This early start to menstruation meant their bodies were exposed to reproductive hormones for a longer stretch of time, which appeared to increase the risk of developing these difficult-to-treat cancers.
Perhaps the most striking finding concerned the duration of breastfeeding. The researchers found that women who breastfed their children for less than two years were much more likely to have the aggressive triple-negative type of cancer. In contrast, women who breastfed for two years or longer had a much lower chance of developing this specific aggressive subtype. The data showed a strong dose-response relationship, meaning that the longer a woman breastfed, the lower her risk of having the most dangerous form of the disease. This protective effect was so strong that women who breastfed for shorter periods had more than three times the odds of having the aggressive triple-negative cancer compared to those who breastfed for longer.
The study also looked at the number of children a woman had. Contrary to some findings in other parts of the world where having many children was sometimes linked to higher risks, in this Ethiopian population, having five or more children was associated with a lower likelihood of developing the aggressive triple-negative cancer. This suggests that in this specific cultural and genetic context, high fertility combined with the long breastfeeding periods common in the region acts as a protective factor. The researchers also found that these patterns held true regardless of whether the women were still menstruating or had already gone through menopause, indicating that these life choices leave a lasting mark on a woman's health that persists for decades.
Despite these clear links between life history and cancer type, the study highlighted a troubling reality about how breast cancer presents in Ethiopia. The vast majority of the women in the study, nearly 70 percent, were already diagnosed with advanced stages of the disease, meaning the cancer had spread significantly by the time they received medical care. This was true for all types of breast cancer, not just the aggressive ones. The high rate of late diagnosis points to a critical need for better public awareness and earlier detection systems, as the window for effective treatment is often missed.
The researchers concluded that a woman's reproductive history is a powerful tool for understanding her risk of developing specific types of breast cancer. The findings suggest that promoting prolonged breastfeeding could be a vital public health strategy in Ethiopia, not just for child health but as a way to reduce the burden of the most aggressive forms of breast cancer. By integrating questions about a woman's reproductive history into routine health assessments, doctors could better identify those at higher risk. However, the study also emphasized that these are associations observed in a specific population and that more research is needed to fully understand the biological mechanisms at work. The immediate priority remains improving access to early diagnosis, ensuring that women are found and treated before the disease reaches an advanced stage.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.